US Patent Issued to KING FAISAL UNIVERSITY on Dec. 10 for "3-(4-bromophenyl)-5-((2-isopropyl-5-methylphenoxy)methyl)-1,2,4-oxadiazole as an anti-cancer and antimicrobial compound" (Saudi Arabia, Egyptian Inventors)

ALEXANDRIA, Va., Dec. 11 -- United States Patent no. 12,162,845, issued on Dec. 10, was assigned to KING FAISAL UNIVERSITY (Al-Ahsa, Saudi Arabia).

"3-(4-bromophenyl)-5-((2-isopropyl-5-methylphenoxy)methyl)-1,2,4-oxadiazole as an anti-cancer and antimicrobial compound" was invented by Hany Mohamed Abd El-Lateef Ahmed (Al-Ahsa, Saudi Arabia), Mai Mostafa Khalaf Ali (Al-Ahsa, Saudi Arabia), Antar Ahmed Abdelhamid Ahmed (Sohag, Egypt) and Amer A. Amer (Sohag, Egypt).

According to the abstract* released by the U.S. Patent & Trademark Office: "A 3-(4-bromophenyl)-5-((2-isopropyl-5-methylphenoxy)methyl)-1.2.4-oxadiazole compound, its synthesis, and its use as an antimicrobial agent."

The patent was filed on Nov. 2, 2023, under Application No. ...